Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Safety and Clinical Activity of the Notch Inhibitor, Crenigacestat (LY3039478), in an Open-Label Phase I Trial Expansion Cohort of Advanced or Metastatic Adenoid Cystic Carcinoma.

C. Even,U. Lassen,J. Merchan,C. Le Tourneau,J-C Soria,C. Ferte,F. Ricci,J. T. Diener,E. Yuen,C. Smith, G. J. Oakley,K. A. Benhadji,Christophe Massard

Investigational new drugs（2019）

Cited 39|Views58
Key words
Adenoid cystic carcinoma,Notch pathway,LY3039478,Crenigacestat,Phase 1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined